Skip to content

Drug interactions

Idelalisib + Medroxyprogesterone

Severity: Moderate

Idelalisib and Medroxyprogesterone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A inhibitor and may increase medroxyprogesterone concentrations. This may amplify dose-related progestin effects including thromboembolic risk and fluid retention.

What this interaction means in plain words

Idelalisib and Medroxyprogesterone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Idelalisib belongs to Oncology; Medroxyprogesterone belongs to Endocrine.

Evidence level: Moderate

Why it happens

Idelalisib strongly inhibits CYP3A4, decreasing medroxyprogesterone metabolism.

What to do

Monitor for progestin adverse effects and consider a lower medroxyprogesterone dose. Consider alternatives if high-dose therapy is used.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idelalisib and Medroxyprogesterone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idelalisib with Medroxyprogesterone?

MediHelp rates the interaction as moderate. Idelalisib and Medroxyprogesterone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Idelalisib is a strong CYP3A inhibitor and may increase medroxyprogesterone concentrations. This may amplify dose-related progestin effects including thromboembolic risk and fluid retention.

How serious is the interaction between Idelalisib and Medroxyprogesterone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for progestin adverse effects and consider a lower medroxyprogesterone dose. Consider alternatives if high-dose therapy is used.

What other medicines interact with Medroxyprogesterone?

MediHelp also lists interactions of Medroxyprogesterone with, for example, Bosentan, Brigatinib, Eslicarbazepine. The full list is on the Medroxyprogesterone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in